Corrigendum to “Transethosomal system for enhanced transdermal delivery and therapeutic effect of caryophyllene oxide” [Int. J. Pharm. 670 (2024) 125111] (International Journal of Pharmaceutics (2025) 670, (S0378517324013450), (10.1016/j.ijpharm.2024.125111))

  • Hiba Natsheh*
  • , Mohammad Qneibi
  • , Naim Kittana
  • , Nidal Jaradat
  • , Mohyeddin Assali
  • , Bahaa Shaqour
  • , Murad Abualhasan
  • , Abdallatif Mayyala
  • , Yaqeen Dawoud
  • , Tala Melhem
  • , Sawsan Abd Alhadi
  • , Osama Hammoudi
  • , Abdullah Samaro
  • , Ahmed Mousa
  • , Sosana Bdir
  • , Mohammad Bdair
  • , Samia Aldwaik
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors regret having omitted the name of the last author Samia Aldwaik in the original version. The correct author list should be as listed above. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number125904
JournalInternational Journal of Pharmaceutics
Volume682
DOIs
StatePublished - 15 Sep 2025
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2025 Elsevier B.V.

Fingerprint

Dive into the research topics of 'Corrigendum to “Transethosomal system for enhanced transdermal delivery and therapeutic effect of caryophyllene oxide” [Int. J. Pharm. 670 (2024) 125111] (International Journal of Pharmaceutics (2025) 670, (S0378517324013450), (10.1016/j.ijpharm.2024.125111))'. Together they form a unique fingerprint.

Cite this